CHI3L1 and malignant colon neoplasm: Low-dose purified CHI3L1 can continuously activate the Wnt/β-catenin pathway and trans-nucleic acid translocation in colon cancer epithelial cells, which has a direct, rather than secondary, effect on inflammation-associated colorectal cancer [128].